AniCell Summer 2016 Newsletter

IN THIS ISSUE

 BioScaff Surgical Products

Clinical Trials for both Dogs and Horses

New Joint Case Study

Grant Award of $250,000

What an incredible last couple of months! AniCell had a great collection season and is excited to introduce our new BioScaff line of surgical products. These products are a customized derivative of our StemWrap line designed for indications such as colic surgery, colon resection, umbilical hernias as well as spays/neuters in dogs. Please contact your veterinarian for these products.

Fresh off our Phase II Field Trials that produced a 79.40% efficacy rate across a variety of pathologies including corneal ulcers, tendon and ligament injuries, performance related OA and superficial wounds, AniCell is working on protocols for a couple clinical trials in horses and dogs. These trials will be in the area of degenerative joint disease in dogs and tendon and ligament injuries in horses.

We have had a couple of new cases written up including a 5 horse study performed this spring on Periarticular Injections of AniMatrX for Performance Related Osteoarthritis. Please review these case studies.

AniCell is pleased to announce that it has received $250,000 grant to further research the use of amnion in tissue related pathologies. AniCell was awarded the grant in early June and is excited to evolve its product line and continue the science of this technology in animals. Please see our blog post category IN THE NEWS BLOG for all the details.

Thanks for collaborating to naturally preserve the ACTIVE life of animals.